Compare AGX & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AGX | TMDX |
|---|---|---|
| Founded | 1961 | 1998 |
| Country | United States | United States |
| Employees | N/A | 728 |
| Industry | Engineering & Construction | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.6B |
| IPO Year | N/A | 2019 |
| Metric | AGX | TMDX |
|---|---|---|
| Price | $352.70 | $138.67 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 8 |
| Target Price | ★ $321.00 | $144.25 |
| AVG Volume (30 Days) | 302.1K | ★ 657.5K |
| Earning Date | 12-04-2025 | 02-26-2026 |
| Dividend Yield | ★ 0.55% | N/A |
| EPS Growth | 76.74 | ★ 170.70 |
| EPS | ★ 8.49 | 2.54 |
| Revenue | ★ $915,030,000.00 | $566,354,000.00 |
| Revenue This Year | $8.37 | $38.73 |
| Revenue Next Year | $28.04 | $20.55 |
| P/E Ratio | ★ $42.84 | $53.35 |
| Revenue Growth | 13.49 | ★ 41.20 |
| 52 Week Low | $101.02 | $58.54 |
| 52 Week High | $400.00 | $156.00 |
| Indicator | AGX | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 53.43 | 55.43 |
| Support Level | $308.58 | $132.02 |
| Resistance Level | $400.00 | $149.22 |
| Average True Range (ATR) | 21.46 | 7.67 |
| MACD | 4.55 | 0.03 |
| Stochastic Oscillator | 50.66 | 51.49 |
Argan Inc is a United States-based construction firm that conducts operations through its wholly-owned subsidiaries, GPS, APC, TRC, and SMC. Through GPS and APC it provides a full range of engineering, procurement, construction, commissioning, maintenance, project development and technical consulting services to the power generation market, including the renewable energy sector, for a wide range of customers, including independent power project owners, public utilities, power plant heavy equipment suppliers and other commercial firms with power requirements in the U.S., Ireland and the U.K. It operates in three segments: Power Services, Industrial Services, and Telecom Services, out of which Power Services derives the majority of revenue.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.